HHS aims to use value-based care payment models to lower drug prices

September 9, 2021Garrett SchmittNo CommentsCMMI, drug prices, HHS, Pharmaceuticals

The Department of Health and Human Services wants to test models that would pay drugs based on their clinical value as part of a new plan to tackle high prices. The plan released Thursday lays out several administrative tools the agency plans to take to address high prices. It also calls on Congress to adopt several reforms…

Recent Posts

  • From Early Detection to Targeted Therapy: How AI is Reframing Precision Medicine
  • What SDS Risk Adjustment Means for Your 2026 Adherence Strategy
  • For TEAM Success, Collaboration Agreements Must Be a Win-Win for Specialists and Hospitals
  • RECORDED WEBINAR: Imagine Having Complete ADT Feeds with Actionable Data
  • Targeting 4 More Years and Scaling Value-Based Care Models in 2026
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us